About: Androgen deprivation therapy influences the uptake of 11C-choline in patients with recurrent prostate cancer: the preliminary results of a sequential PET/CT study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Androgen deprivation therapy influences the uptake of 11C-choline in patients with recurrent prostate cancer: the preliminary results of a sequential PET/CT study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 06 July 2011

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в листопаді 2011 (uk) article scientifique publié en 2011 (fr) im Juli 2011 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 06 July 2011 (en) artículu científicu espublizáu en xunetu de 2011 (ast)
publication date	wds:Q56984031-62C35EF8-B405-4783-AFFA-07A763BC9F0B
publication date	2011-07-06 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q56984031-3ECA0994-3D4D-4CFB-B2F4-A7DC2A9C1605
language of work or name	English
exact match	wds:Q56984031-C022AE0F-7D69-427A-9D9D-A74010861826
exact match	https://scigraph.springernature.com/pub.10.1007/s00259-011-1867-0
cites work	wds:Q56984031-2D46886E-23BC-4A99-B8B3-062175F13C1B wds:Q56984031-329D79D6-1E20-41AD-B070-F36A4F0D25C2 wds:Q56984031-344233DE-C955-4C73-B842-4B28D765436A wds:Q56984031-42F31832-9F45-436A-A424-06946746288A wds:Q56984031-463B6F04-603B-4660-B264-EAC35D4966A5 wds:Q56984031-48C830F7-53B7-4ED9-AD08-68F1AD81A301 wds:Q56984031-5C530FD9-7B9C-48B8-B9C5-47797470FFB9 wds:Q56984031-5FA3F845-175A-419E-882A-C999D18F0A82 wds:Q56984031-632480BA-EC36-4353-8314-CF77E6AB4ECE wds:Q56984031-79CA1F52-8D4D-4C01-A5BD-23F561ABC688 wds:Q56984031-8A7611B8-A285-4D16-B7BB-DF9274742DAE wds:Q56984031-92AE0A79-5315-40A5-A122-F1A9CD4F4563 wds:Q56984031-92BEC0E1-B9D8-4BB4-971F-13BFA04FB91D wds:Q56984031-94F5F132-02E2-41DD-8EFB-7293FD346BCC wds:Q56984031-9F25ECC4-89E5-4317-8432-A32AD8BD894C wds:Q56984031-A174D61D-3A21-4889-8489-8157999D3F12 wds:Q56984031-A4C6102A-EF5B-4BAC-A5E5-619F75029969 wds:Q56984031-B03B1021-AA25-477C-8413-7D495B2964D6 wds:Q56984031-B322CB2F-1254-4BC2-93BB-95B014CAE3F9 wds:Q56984031-B77D9362-925B-44BE-99BC-AA03B4C754FF wds:Q56984031-BA8D57BF-49AA-4A03-9877-48B6B8BBD34F wds:Q56984031-C1F56F24-28CA-4BAD-AE0E-D763120889B2 wds:Q56984031-C80F9A46-B815-451D-8190-9D77E295A77D wds:Q56984031-F15616CB-CC62-498A-8E5D-E11C373EBA54 wds:Q56984031-F4ACC800-0D44-4177-922B-07F50C860862
cites work	Role of MRI in follow-up after focal therapy for prostate carcinoma EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. Choline PET/CT for prostate cancer: main clinical applications Tumour phospholipid metabolism The role of hormonal treatment in prostate cancer. Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography. Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy Influence of trigger PSA and PSA kinetics on 11C-Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy Is there a role for ¹¹C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml? In vivo uptake of [11C]choline does not correlate with cell proliferation in human prostate cancer [methyl-3H]Choline incorporation into MCF7 tumour cells: correlation with proliferation. PSA doubling time for prediction of [(11)C]choline PET/CT findings in prostate cancer patients with biochemical failure after radical prostatectomy [(11)C]choline uptake with PET/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumour stage and anti-androgenic therapy The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer. Novel tracers and their development for the imaging of metastatic prostate cancer Efficacy of prostatic fossa biopsy in detecting local recurrence after radical prostatectomy Predictors of metastatic disease in men with biochemical failure following radical prostatectomy. Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy Radionuclide bone scintigraphy in patients with biochemical recurrence after radical prostatectomy: when is it indicated? Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence. Bicalutamide ('Casodex') 150 mg as adjuvant to radiotherapy in patients with localised or locally advanced prostate cancer: results from the randomised Early Prostate Cancer Programme A model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapy ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of prostate cancer PET in genitourinary tract cancers. [Methyl-3H]-choline incorporation into MCF-7 cells: correlation with proliferation, choline kinase and phospholipase D assay.
author name string	wds:Q56984031-034BEE7C-12E9-41E4-9630-A5187C723220 wds:Q56984031-23E61341-3555-4E39-ABBE-2BE47A27D73F wds:Q56984031-2BAF05EE-7B73-476C-8A97-DE1690197D44 wds:Q56984031-37F43FCE-0E69-467B-BA58-03F03C0D586F wds:Q56984031-4FA840D0-6B74-42D3-BCCC-95E2E5781558 wds:Q56984031-5817DBA9-1C1C-44F8-BBFC-767B4EB835B7 wds:Q56984031-775DF893-217C-4C17-B664-65BFA0D6F213 wds:Q56984031-81BC77A6-677A-4C63-8770-BC065F80257C wds:Q56984031-B298E2BC-4E59-4279-8483-83D4D92249AA wds:Q56984031-F9E80234-9FC3-419D-AB7E-EE8AF46D835B
author name string	Riccardo Schiavina Paolo Castellucci Giuseppe Martorana Domenico Rubello Maria Cristina Marzola Stefano Fanti Monica Celli Chiara Fuccio Claudio Malizia Marta Barios Profitos
rdfs:label	Androgen deprivation therapy influences the uptake of 11C-choline in patients with recurrent prostate cancer: the preliminary results of a sequential PET/CT study (en) Androgen deprivation therapy influences the uptake of 11C-choline in patients with recurrent prostate cancer: the preliminary results of a sequential PET/CT study (nl)
skos:prefLabel	Androgen deprivation therapy influences the uptake of 11C-choline in patients with recurrent prostate cancer: the preliminary results of a sequential PET/CT study (en) Androgen deprivation therapy influences the uptake of 11C-choline in patients with recurrent prostate cancer: the preliminary results of a sequential PET/CT study (nl)
name	Androgen deprivation therapy influences the uptake of 11C-choline in patients with recurrent prostate cancer: the preliminary results of a sequential PET/CT study (en) Androgen deprivation therapy influences the uptake of 11C-choline in patients with recurrent prostate cancer: the preliminary results of a sequential PET/CT study (nl)
author	wds:Q56984031-A8254EBE-A4E0-495F-A755-8B12F264AE85
author	Cinzia Pettinato
title	wds:Q56984031-B12DF91F-B9B4-415F-8E6B-1B1C82D135AF
title	Androgen deprivation therapy influences the uptake of 11C-choline in patients with recurrent prostate cancer: the preliminary results of a sequential PET/CT study (en)
page(s)	wds:Q56984031-F730649C-06DC-4583-B02F-0CB99651EA87
page(s)	1985-1989
instance of	wds:Q56984031-132E7E16-EC4D-4BD6-BF17-E131762021E5
instance of	scholarly article
main subject	wds:Q56984031-0FACA23D-63C3-4B5D-9825-BACE23AC647F wds:Q56984031-86C53AD3-7882-47E7-AFF2-A8A5A0A9076F
main subject	prostate cancer

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software